SYK vs. EW
SYK (Stryker Corporation) and EW (Edwards Lifesciences Corporation) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 10 years, SYK returned 11.18%/yr vs 9.98%/yr for EW. At a 0.44 correlation, their price movements are largely independent.
Performance
SYK vs. EW - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SYK achieves a -16.32% return, which is significantly lower than EW's 2.83% return. Over the past 10 years, SYK has outperformed EW with an annualized return of 11.18%, while EW has yielded a comparatively lower 9.98% annualized return.
SYK
- 1D
- -2.06%
- 1M
- -0.49%
- YTD
- -16.32%
- 6M
- -19.60%
- 1Y
- -22.25%
- 3Y*
- 2.76%
- 5Y*
- 4.34%
- 10Y*
- 11.18%
EW
- 1D
- -0.57%
- 1M
- 4.38%
- YTD
- 2.83%
- 6M
- 3.48%
- 1Y
- 12.24%
- 3Y*
- 0.90%
- 5Y*
- -1.46%
- 10Y*
- 9.98%
SYK vs. EW - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SYK Stryker Corporation | -16.32% | -1.48% | 21.34% | 23.80% | -7.42% | 10.22% | 18.17% | 35.33% | 2.43% | 30.84% |
EW Edwards Lifesciences Corporation | 2.83% | 15.16% | -2.91% | 2.20% | -42.41% | 42.00% | 17.32% | 52.31% | 35.90% | 20.29% |
Correlation
The correlation between SYK and EW is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.44 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.55 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.57 |
Correlation (All Time) Calculated using the full available price history since Mar 28, 2000 | 0.44 |
The correlation between SYK and EW shifts across timeframes, from 0.43 (1 year) to 0.57 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
SYK:
$113.36B
EW:
$50.90B
SYK:
$8.63
EW:
$1.87
SYK:
33.97
EW:
46.85
SYK:
2.52
EW:
1.51
SYK:
4.49
EW:
8.12
SYK:
2.45
EW:
4.93
SYK:
$25.27B
EW:
$6.30B
SYK:
$16.09B
EW:
$4.92B
SYK:
$5.48B
EW:
$1.44B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SYK vs. EW — Risk / Return Rank
SYK
EW
SYK vs. EW - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Stryker Corporation (SYK) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SYK | EW | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.01 | 0.52 | -1.53 |
Sortino ratioReturn per unit of downside risk | -1.38 | 0.94 | -2.33 |
Omega ratioGain probability vs. loss probability | 0.84 | 1.11 | -0.27 |
Calmar ratioReturn relative to maximum drawdown | -0.77 | 0.95 | -1.72 |
Martin ratioReturn relative to average drawdown | -1.92 | 2.33 | -4.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SYK | EW | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.01 | 0.52 | -1.53 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | -0.04 | +0.23 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | 0.31 | +0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.55 | 0.52 | +0.03 |
Drawdowns
SYK vs. EW - Drawdown Comparison
The maximum SYK drawdown since its inception was -58.63%, which is greater than EW's maximum drawdown of -54.32%. Use the drawdown chart below to compare losses from any high point for SYK and EW.
Loading charts...
Drawdown Indicators
| SYK | EW | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.63% | -54.32% | -4.31% |
Max Drawdown (1Y)Largest decline over 1 year | -29.45% | -12.73% | -16.72% |
Max Drawdown (3Y)Largest decline over 3 years | -29.45% | -37.53% | +8.08% |
Max Drawdown (5Y)Largest decline over 5 years | -31.68% | -54.32% | +22.64% |
Max Drawdown (10Y)Largest decline over 10 years | -43.80% | -54.32% | +10.52% |
Current DrawdownCurrent decline from peak | -26.77% | -32.92% | +6.15% |
Average DrawdownAverage peak-to-trough decline | -13.10% | -14.46% | +1.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.76% | 5.19% | +6.57% |
Volatility
SYK vs. EW - Volatility Comparison
Stryker Corporation (SYK) has a higher volatility of 8.61% compared to Edwards Lifesciences Corporation (EW) at 8.07%. This indicates that SYK's price experiences larger fluctuations and is considered to be riskier than EW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SYK | EW | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.61% | 8.07% | +0.54% |
Volatility (6M)Calculated over the trailing 6-month period | 17.77% | 18.68% | -0.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.03% | 23.84% | -1.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.13% | 32.60% | -8.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.31% | 32.24% | -5.93% |
Dividends
SYK vs. EW - Dividend Comparison
SYK's dividend yield for the trailing twelve months is around 1.17%, while EW has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EW Edwards Lifesciences Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SYK Stryker Corporation | 1.17% | 0.97% | 0.90% | 1.02% | 1.16% | 0.97% | 0.96% | 1.02% | 1.23% | 1.13% | 1.31% | 1.52% |
Financials
SYK vs. EW - Financials Comparison
This section allows you to compare key financial metrics between Stryker Corporation and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SYK vs. EW - Profitability Comparison
SYK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Stryker Corporation reported a gross profit of 3.81B and revenue of 6.02B. Therefore, the gross margin over that period was 63.3%.
EW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a gross profit of 1.29B and revenue of 1.65B. Therefore, the gross margin over that period was 78.2%.
SYK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Stryker Corporation reported an operating income of 936.00M and revenue of 6.02B, resulting in an operating margin of 15.6%.
EW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported an operating income of 514.70M and revenue of 1.65B, resulting in an operating margin of 31.2%.
SYK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Stryker Corporation reported a net income of 745.00M and revenue of 6.02B, resulting in a net margin of 12.4%.
EW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Edwards Lifesciences Corporation reported a net income of 380.70M and revenue of 1.65B, resulting in a net margin of 23.1%.
Frequently Asked Questions
SYK and EW have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SYK has higher volatility (8.61%) compared to EW (8.07%). In terms of maximum drawdown, SYK dropped -58.63% vs EW's -54.32%.
EW currently has the higher Sharpe Ratio (0.52 vs -1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SYK and EW
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer